12th-18th June is Cervical Cancer screening awareness week. Menarini Diagnostics are proud to offer key cervical antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

In females in the UK, cervical cancer is the 14th most common cancer, contributing to approximately 2% of all new cancer cases and 1% of all cancer deaths yearly. Those with cervical cancer have a five year survival rate of  67%.

Cervical Cancer Antibody Factsheet

Cancer Research UK, http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/cervical-cancer, Accessed [April] [2018]